Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
Ulrich WahnClaus BachertJoachim HeinrichHartmut RichterStefan ZielenPublished in: Allergy (2018)
Birch pollen AIT demonstrated real-world benefits up to 6 years post-treatment cessation through significantly reduced AR and asthma medication intake, and significantly decreased risk of new-onset asthma medication use on-treatment.